Clinical significance of serum tumour M2-PK and CA19-9 detection in the diagnosis of cholangiocarcinoma

Kobayashi, 2000, Incidence of primary cholangiocellular carcinoma of the liver in Japanese patients with hepatitis C virus-related cirrhosis, Cancer, 88, 2471, 10.1002/1097-0142(20000601)88:11<2471::AID-CNCR7>3.0.CO;2-T Shaib, 2005, Risk factors of intrahepatic cholangiocarcinoma in the United States: a case–control study, Gastroenterology, 128, 620, 10.1053/j.gastro.2004.12.048 Eigenbrodt, 1992, Double role for pyruvate kinase type M2 in the expansion of phosphometabolite pools found in tumor cells, Crit Rev Oncog, 3, 91 Eigenbrodt, 1998, Pyruvate kinase and the interaction of amino acid and carbohydrate metabolism in solid tumors, Anticancer Res, 18, 3267 Eigenbrodt, 1997, Quantification of tumor type M2 pyruvate kinase (Tu M2-PK) in human carcinomas, Anticancer Res, 17, 3153 Oremek, 1999, The pyruvate kinase isoenzyme tumor M2 (Tu M2-PK) as a tumor marker for renal carcinoma, Anticancer Res, 19, 2599 Lüftner, 2000, Tumor type M2 pyruvate kinase expression in advanced breast cancer, Anticancer Res, 20, 5077 Schneider, 2000, Quantitative detection of tumor M2-pyruvate kinase in plasma of patients with lung cancer in comparison to other lung diseases, Cancer Detect Prev, 24, 531 Hardt, 2000, Tumor M2-pyruvate kinase: a promising tumor marker in the diagnosis of gastro-intestinal cancer, Anticancer Res, 20, 4965 Schulze, 2000, The tumor marker tumor M2-PK: an application in the diagnosis of gastrointestinal cancer, Anticancer Res, 20, 4961 Burgos San Juan, 2008, Cholangiocarcinoma, Rev Med Child, 136, 240 Farhat, 2008, Prognostic factors in patients with advanced cholangiocarcinoma: role of surgery, chemotherapy and body mass index, World J Gastroenterol, 14, 3224, 10.3748/wjg.14.3224 Lempinen, 2007, Enhanced detection of cholangiocarcinoma with serum trypsinogen-2 in patients with severe bile duct strictures, J Hepatol, 47, 677, 10.1016/j.jhep.2007.05.017 Pezzilli, 2003, Diagnostic value of tumor M2-pyruvate kinase in neuroendocrine tumors. A comparative study with chromogranin A, Anticancer Res, 23, 2969